Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Giovanni Martinotti, Rita Santacroce, Mauro Pettorruso, et al.
Brain Sciences (2018) Vol. 8, Iss. 3, pp. 47-47
Open Access | Times Cited: 146

Showing 51-75 of 146 citing articles:

The Viability of Microdosing Psychedelics as a Strategy to Enhance Cognition and Well-being - An Early Review
Joel Bornemann
Journal of Psychoactive Drugs (2020) Vol. 52, Iss. 4, pp. 300-308
Open Access | Times Cited: 20
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Ozan Eren, Florian Schöberl, Christoph J. Schankin, et al.
European Journal of Clinical Pharmacology (2020) Vol. 77, Iss. 2, pp. 271-272
Open Access | Times Cited: 20
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges
Mauro Scala, Chiara Fabbri, Paolo Fusar‐Poli, et al.
CNS Spectrums (2024), pp. 1-15
Closed Access | Times Cited: 2
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Davide Arillotta, Amira Guirguis, John Corkery, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 907-907
Open Access | Times Cited: 15
Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: A Systematic Review of the Current Literature
Alessio Mosca, Stefania Chiappini, Andrea Miuli, et al.
Current Neuropharmacology (2022) Vol. 21, Iss. 11, pp. 2178-2194
Open Access | Times Cited: 10
Not All Cases of Visual Snows are Benign: Mimics of Visual Snow Syndrome
Chenyue Hang, Lakshmi Leishangthem, Yan Yan
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 3293-3300
Open Access | Times Cited: 14
Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
Lukas A. Basedow, Thomas G. Riemer, Simon Reiche, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 13
Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
Aurora Savino, Charles D. Nichols
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 9-23
Open Access | Times Cited: 13
Psychedelic science in post-COVID-19 psychiatry
John R. Kelly, Matthew T. Crockett, Laith Alexander, et al.
Irish Journal of Psychological Medicine (2020) Vol. 38, Iss. 2, pp. 93-98
Open Access | Times Cited: 14
A Systematic Study of Microdosing Psychedelics
Vince Polito, Dick stevenson
(2018)
Open Access | Times Cited: 13
Acquired synaesthesia following 2C-B use
Steliana Yanakieva, David Luke, Ashok Jansari, et al.
Psychopharmacology (2019) Vol. 236, Iss. 7, pp. 2287-2289
Closed Access | Times Cited: 12
Cross-validation of the ego dissolution scale: implications for studying psychedelics
Steven Jay Lynn, Charlie W. McDonald, Fiona G. Sleight, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 4
Understanding marijuana use initiation vs. frequency of use on risk for hallucinogen use: testing for mediating mechanisms underlying the gateway hypothesis
Thomas Wojciechowski
Criminal Justice Studies (2024) Vol. 37, Iss. 2, pp. 171-191
Open Access | Times Cited: 1
Persistent aura, visual snow, and other visual symptoms
Carrie E. Robertson, Kathleen B. Digre
Handbook of clinical neurology (2024), pp. 441-464
Closed Access | Times Cited: 1
Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls
Georg Leistenschneider, Tomislav Majić, Simon Reiche, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
New Psychoactive Substances (NPS), Psychedelic Experiences and Dissociation: Clinical and Clinical Pharmacological Issues
Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini, et al.
Current Addiction Reports (2019) Vol. 6, Iss. 2, pp. 140-152
Open Access | Times Cited: 11
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer
Brian S. Barnett, George Greer
Journal of the Academy of Consultation-Liaison Psychiatry (2021) Vol. 62, Iss. 4, pp. 460-471
Closed Access | Times Cited: 10
Substance-Related and Addictive Disorders

American Psychiatric Association Publishing eBooks (2022)
Closed Access | Times Cited: 7
Club Drugs and Novel Psychoactive Substances
Owen Bowden‐Jones, Dima Abdulrahim
(2020)
Closed Access | Times Cited: 9
Pharmacologic Similarities and Differences Among Hallucinogens
Kristin Waters
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. S2
Open Access | Times Cited: 9
Pathological Delta Oscillations in Hallucinogen Persisting Perception Disorder: A Case Report
David Haslacher, Nikolina Novkovic, Maria Buthut, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 6
Predictors Of Hallucinogen Persisting Perception Disorder Symptoms, Delusional Ideation And Magical Thinking Following Naturalistic Psychedelic Use
Katie Zhou, D. de Wied, Robin Carhart‐Harris, et al.
(2022)
Open Access | Times Cited: 6
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence
Thomas Knuijver, Maarten Belgers, Wiebren Markus, et al.
Journal of Clinical Psychopharmacology (2018) Vol. 38, Iss. 6, pp. 646-648
Open Access | Times Cited: 9
Toxicity of psychedelic drugs
Daniela Călina, Félix Carvalho, Anca Oana Docea
Elsevier eBooks (2021), pp. 545-556
Closed Access | Times Cited: 8
The Immunoseasonal Theory of Psychiatric Disorders
Napoleon Waszkiewicz
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4615-4615
Open Access | Times Cited: 3

Scroll to top